TWI796278B - Chemo-brain image visualization classifying system and operating method thereof - Google Patents
Chemo-brain image visualization classifying system and operating method thereof Download PDFInfo
- Publication number
- TWI796278B TWI796278B TW111138792A TW111138792A TWI796278B TW I796278 B TWI796278 B TW I796278B TW 111138792 A TW111138792 A TW 111138792A TW 111138792 A TW111138792 A TW 111138792A TW I796278 B TWI796278 B TW I796278B
- Authority
- TW
- Taiwan
- Prior art keywords
- brain
- image
- whole
- classification system
- chemotherapy
- Prior art date
Links
Images
Abstract
Description
本發明為一種化療腦影像可視化分類系統及其運作方法,尤指一種可以透過並同時運用訓練好的體積卷積神經網路(Volumetric Convolutional Neural Network)模型和積分梯度(integrated gradients)演算法,將磁共振成像(Magnetic resonance imaging, MRI)影像進行預測,並依據預測結果進行分類以及可視化的化療腦影像可視化分類系統及其運作方法。The present invention is a chemotherapy brain image visualization classification system and its operation method, in particular, a trained Volume Convolutional Neural Network (Volumetric Convolutional Neural Network) model and integrated gradients (integrated gradients) algorithm can be used simultaneously to convert Magnetic resonance imaging (Magnetic resonance imaging, MRI) images are predicted, classified and visualized based on the predicted results, and the chemotherapy brain image visualization classification system and its operation method.
以現代化的社會而言,癌症已經成為人類晚年最大的殺手。其中,乳癌是全球最常見的女性癌症。在所有乳癌的治療方式中,接受過化療的乳癌倖存者可能會在癌症治療期間或之後產生認知障礙。一般而言,這種現象稱為化學腦(chemo-brain)。In modern society, cancer has become the biggest killer of human beings in their later years. Among them, breast cancer is the most common female cancer in the world. As with all breast cancer treatment modalities, breast cancer survivors who have undergone chemotherapy may experience cognitive impairment during or after cancer treatment. Generally speaking, this phenomenon is called chemical brain (chemo-brain).
所謂化學腦(chemo-brain)通常用來描述接受全身化療後的認知功能變化。而由於化學腦(chemo-brain)的影響,一般有此現象的倖存者多半無法準確地描述其病況。舉例而言,傳統醫護會使用認知評估量表進行測驗並與病人交流;然而,對於具有化學腦(chemo-brain)的病人來說,可能無法避免病人不實回答的情況產生。進一步影響後續第一時間的治療以及追蹤。The so-called chemo-brain is often used to describe changes in cognitive function after systemic chemotherapy. Due to the influence of the chemical brain (chemo-brain), most survivors with this phenomenon cannot accurately describe their condition. For example, traditional doctors and nurses will use cognitive assessment scales to conduct tests and communicate with patients; however, for patients with a chemo-brain, it may be unavoidable for patients to give false answers. It will further affect the follow-up treatment and follow-up at the first time.
此外,有鑑於化學腦(chemo-brain)實際上非常難以用肉眼直接從磁共振成像(Magnetic resonance imaging, MRI)影像辨識;因此,目前亟需一種具有客觀性的判讀系統,以輔助判斷倖存者是否具有化學腦(chemo-brain)的可能性。In addition, in view of the fact that the chemical brain (chemo-brain) is actually very difficult to identify directly from the magnetic resonance imaging (MRI) images with the naked eye; therefore, an objective interpretation system is urgently needed to assist in judging survivors Whether it has the possibility of chemical brain (chemo-brain).
為了解決先前技術中所提到的問題,本發明提供了一種化療腦影像可視化分類系統。所述化療腦影像可視化分類系統係用以運行後述化療腦影像可視化分類系統的運作方法。具體來說,該部影像可視化分類系統包含一處理模組以及至少一儲存模組。其中,該至少一儲存模組與該處理模組連接。In order to solve the problems mentioned in the prior art, the present invention provides a visual classification system for chemotherapy brain images. The chemotherapy brain image visualization classification system is used to run the operation method of the chemotherapy brain image visualization classification system described later. Specifically, the image visual classification system includes a processing module and at least one storage module. Wherein, the at least one storage module is connected with the processing module.
進一步地,所述化療腦影像可視化分類系統的運作方法主要由下列步驟所組成。首先,步驟(A)係提供至少一原始全腦磁振造影影像予以一處理模組。接著,步驟(B)由該處理模組對該至少一原始全腦磁振造影影像執行一影像前處理手段,獲得至少一前處理後全腦磁振造影影像。Further, the operating method of the visualization classification system for chemotherapy brain images mainly consists of the following steps. Firstly, step (A) is to provide at least one original whole brain MRI image to a processing module. Next, in step (B), the processing module executes an image pre-processing means on the at least one original whole-brain MRI image to obtain at least one pre-processed whole-brain MRI image.
接著,步驟(C)係由該處理模組對該至少一前處理後全腦磁振造影影像擷取出至少一全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊。Next, the step (C) is to extract at least one mean fractional amplitude of low-frequency fluctuations (Mean fractional amplitude of low-frequency fluctuations, mfALFF) of the whole brain from the at least one pre-processed whole brain MRI image by the processing module. Information.
而步驟(D)則由該處理模組將該至少一全腦平均低頻波動振幅度分率資訊輸入一體積卷積神經網路(Volumetric Convolutional Neural Network)模型進行預測,並得到至少一全腦預測結果。In step (D), the processing module inputs the at least one whole-brain average low-frequency fluctuation amplitude fraction information into a volumetric convolutional neural network (Volumetric Convolutional Neural Network) model for prediction, and obtains at least one whole-brain prediction result.
最後,步驟(E)係由該處理模組透過一積分梯度(integrated gradients)演算法將該至少一全腦預測結果轉換為至少一全腦腦區影像。其中,該體積卷積神經網路模型包含3D-ResNet-50深度學習模型及3D-DenseNet-121深度學習模型。Finally, in step (E), the processing module converts the at least one whole-brain prediction result into at least one whole-brain region image through an integrated gradients algorithm. Among them, the volumetric convolutional neural network model includes 3D-ResNet-50 deep learning model and 3D-DenseNet-121 deep learning model.
以上對本發明的簡述,目的在於對本發明之數種面向和技術特徵作一基本說明。發明簡述並非對本發明的詳細表述,因此其目的不在特別列舉本發明的關鍵性或重要元件,也不是用來界定本發明的範圍,僅為以簡明的方式呈現本發明的數種概念而已。The purpose of the above brief description of the present invention is to make a basic description of several aspects and technical features of the present invention. The summary of the invention is not a detailed description of the invention, so it is not intended to specifically list the key or important elements of the invention, nor is it used to define the scope of the invention, but to present several concepts of the invention in a concise manner.
為能瞭解本發明的技術特徵及實用功效,並可依照說明書的內容來實施,茲進一步以如圖式所示的較佳實施例,詳細說明如後:In order to understand the technical features and practical effects of the present invention, and to implement it according to the contents of the specification, the preferred embodiment shown in the drawings will be described in detail as follows:
首先請先參照圖1,圖1係本發明化療腦影像可視化分類系統實施例之系統架構圖。如圖1所示,本實施例之化療腦影像可視化分類系統10主要由處裡模組100以及與處理模組100連接的儲存模組200a和儲存模組200b所構成。First, please refer to FIG. 1. FIG. 1 is a system architecture diagram of an embodiment of the visualization classification system for chemotherapy brain images of the present invention. As shown in FIG. 1 , the visualized
進一步地來說,本實施例之處理模組100可以是中央處理器(Central Processing Unit, CPU)、微處理器(Microprocessor)、圖形處理器(Graphics Processing Unit, GPU)、特定應用積體電路(Application Specific Integrated Circuit, ASIC)或其組合。而儲存模組200a或200b則可以是隨機存取記憶體(RAM)、唯讀記憶體(ROM)、快閃記憶體(flash memory)、硬碟(hard disk)、軟碟(soft disk)、資料庫(database)或其組合。本發明並不加以限制。Further, the
在本實施例中,儲存模組200a較佳地可以實施為如隨機存取記憶體(RAM)、唯讀記憶體(ROM)、快閃記憶體(flash memory)、硬碟(hard disk)或軟碟(soft disk)等具有記憶功能的硬體。相對地,儲存模組200b則可以是例如雲端等資料庫(database)。In this embodiment, the
在本實施例中,儲存模組200a和儲存模組200b可用於但不限於儲存所有處理模組100會需要運行或運用到的軟體、演算法、程式、資料集(Data set)等,本發明並不加以限制。In this embodiment, the
接著請參照圖2,圖2係本發明化療腦影像可視化分類系統的運作方法實施例之流程圖。具體來說,圖2中所示的化療腦影像可視化分類系統的運作方法係運行於圖1中所示化療腦影像可視化分類系統10的環境架構之下。Next, please refer to FIG. 2 . FIG. 2 is a flow chart of an embodiment of the operating method of the chemotherapy brain image visualization classification system of the present invention. Specifically, the operation method of the visualization classification system for chemotherapy brain images shown in FIG. 2 runs under the environment framework of the
以本實施例而言,在執行該化療腦影像可視化分類系統的運作方法之前必須先訓練好可應用於本實施例的體積卷積神經網路(Volumetric Convolutional Neural Network)模型。According to this embodiment, before implementing the operation method of the chemotherapy brain image visualization classification system, the volumetric convolutional neural network (Volumetric Convolutional Neural Network) model applicable to this embodiment must be trained.
具體來說,本實施例之體積卷積神經網路模型包含3D-ResNet-50深度學習模型及3D-DenseNet-121深度學習模型。其中,該3D-ResNet-50深度學習模型係將壓縮-激勵塊(SE-block)透過殘差連接(Skip Connection)嵌入ResNet-50深度學習模型所形成。而該3D-DenseNet-121深度學習模型係將壓縮-激勵塊(SE-block)嵌入DenseNet-121深度學習模型的密集塊(dense block)所形成。並且,該3D-ResNet-50深度學習模型透過殘差連接(Skip Connection)嵌入DenseNet-121深度學習模型的密集塊(dense block)嵌入的壓縮-激勵塊(SE-block)。據此,使本實施例之3D-ResNet-50深度學習模型及3D-DenseNet-121深度學習模型得以緊密連接。Specifically, the volumetric convolutional neural network model in this embodiment includes a 3D-ResNet-50 deep learning model and a 3D-DenseNet-121 deep learning model. Among them, the 3D-ResNet-50 deep learning model is formed by embedding the compression-excitation block (SE-block) into the ResNet-50 deep learning model through the residual connection (Skip Connection). The 3D-DenseNet-121 deep learning model is formed by embedding the compression-excitation block (SE-block) into the dense block of the DenseNet-121 deep learning model. Moreover, the 3D-ResNet-50 deep learning model embeds the compression-excitation block (SE-block) embedded in the dense block (dense block) of the DenseNet-121 deep learning model through the residual connection (Skip Connection). Accordingly, the 3D-ResNet-50 deep learning model and the 3D-DenseNet-121 deep learning model of this embodiment are closely connected.
接著,本實施例蒐集了55名的乳癌化療後倖存者以及65名的健康對照組資訊,用以訓練本實施例之體積卷積神經網路模型。首先,本實施例針對影像處理的運算需求均透過化療腦影像可視化分類系統10據以實現,合先敘明。Next, in this embodiment, the information of 55 breast cancer survivors after chemotherapy and 65 healthy control groups was collected to train the volume convolutional neural network model of this embodiment. First of all, the calculation requirements for image processing in this embodiment are all realized through the visualization and
具體來說,本實施例一共120名的受試者係以功能性磁振造影(functional Magnetic Resonance Imaging, fMRI)的方式獲取原始全腦磁振造影影像。在此階段中,功能性磁振造影(functional Magnetic Resonance Imaging, fMRI)的掃瞄參數設定為TR/TE = 2000/30毫秒、翻轉角度(flip angle )為 90 ◦、 NEX = 1、 FOV = 220 × 220 mm 2、 矩陣尺寸(matrix size )= 64 × 64 以及立體像素尺寸( voxel size )= 3.4 × 3.4 × 4 mm 3。最後,將擷取出31個軸影像( axial images )用以涵蓋全腦的範圍。其中,每個靜息態功能性磁振造影(resting-state fMRI)運行包含300個影像體積(image volumes)。整體的掃描時長約為10分鐘。 Specifically, in this embodiment, a total of 120 subjects obtained original whole-brain MRI images by means of functional Magnetic Resonance Imaging (fMRI). In this stage, the scanning parameters of functional Magnetic Resonance Imaging (fMRI) were set as TR/TE = 2000/30 milliseconds, flip angle (flip angle) was 90 ◦ , NEX = 1, FOV = 220 × 220 mm 2 , matrix size = 64 × 64 and voxel size = 3.4 × 3.4 × 4 mm 3 . Finally, 31 axial images will be extracted to cover the whole brain. Each resting-state fMRI run contained 300 image volumes. The overall scan time is about 10 minutes.
接著,所獲得的原始全腦磁振造影影像將以影像前處理手段來處理成可以輸入並用以訓練本實施例之體積卷積神經網路模型的樣態。具體來說,前階段取得的原始全腦磁振造影影像係以統計參數圖譜(Statistical Parametric Mapping, SPM)處理之。在本實施例中,所述統計參數圖譜(Statistical Parametric Mapping, SPM)以SPM12(Wellcome Department of Cognitive Neurology, London, UK)此一軟體執行。而執行的步驟包含切片時序校正(Slice Timing)校正步驟、位移校正(Realignment)步驟、標準化(Normalization)步驟、空間平滑化(Smoothing)步驟或其組合,僅依照原始全腦磁振造影影像的實際狀況調整,本發明並不加以限制。Next, the obtained original whole-brain MRI images will be processed by means of image pre-processing into a state that can be input and used to train the volume convolutional neural network model of this embodiment. Specifically, the original whole-brain MRI images obtained in the previous stage were processed with Statistical Parametric Mapping (SPM). In this embodiment, the Statistical Parametric Mapping (SPM) is implemented by software SPM12 (Wellcome Department of Cognitive Neurology, London, UK). The steps performed include slice timing correction (Slice Timing) correction step, displacement correction (Realignment) step, normalization (Normalization) step, spatial smoothing (Smoothing) step or a combination thereof, only according to the actual situation of the original whole brain MRI image. Condition adjustment is not limited by the present invention.
具體來說,本實施例於執行影像前處理手段後會透過一篩除標準排除不適格的該至少一原始全腦磁振造影影像。該篩除標準係排除頭部動作(Head motion)之平移(Translation)距離超過1毫米(mm)或頭部動作(Head motion)之旋轉(Rotation)角度超過1度的該至少一原始全腦磁振造影影像。Specifically, in this embodiment, after performing the image pre-processing means, the unqualified at least one original whole-brain MRI image will be excluded through a screening criterion. The screening criteria are to exclude the at least one original whole-brain magnetic field whose head motion (Translation) distance exceeds 1 millimeter (mm) or head motion (Head motion) rotation (Rotation) angle exceeds 1 degree Vibration imaging.
而當本實施例之影像前處理手段執行標準化(Normalization)步驟時,該標準化(Normalization)步驟係將經過該位移校正(Realignment)步驟後的該至少一原始全腦磁振造影影像以MNI空間(Standard Montreal Neurological Institute space)作為樣版腦後,以3毫米各向同性立體像素(isotropic 3 mm voxels)進行標準化。And when the image pre-processing means of this embodiment executes the normalization (Normalization) step, the normalization (Normalization) step is the at least one original whole-brain MRI image after the displacement correction (Realignment) step in the MNI space ( Standard Montreal Neurological Institute space) was used as the sample back of the brain, and was standardized with 3 mm isotropic voxels (isotropic 3 mm voxels).
進一步地,而當本實施例之影像前處理手段執行空間平滑化(Smoothing)步驟時,該空間平滑化(Smoothing)步驟係以6毫米(mm)半峰全寬(Full width at half maximum, FWHM)的高斯濾波器(Gaussian filter)放大該至少一原始全腦磁振造影影像的訊號雜訊比(Signal-to-noise ratio)。Further, when the image pre-processing means of this embodiment executes the spatial smoothing (Smoothing) step, the spatial smoothing (Smoothing) step is 6 millimeters (mm) full width at half maximum (Full width at half maximum, FWHM ) Gaussian filter (Gaussian filter) to amplify the signal-to-noise ratio of the at least one original whole-brain MRI image.
最後,經影像前處理手段處理完畢的前處理後全腦磁振造影影像,本實施例會進一步透過一帶通濾波器(band pass filter)過濾頻率介於0.01-0.12赫茲(Hz)的該前處理後全腦磁振造影影像。據此,以擷取出得以用於訓練的全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊。在本實施例中,運行過濾頻率介於0.01-0.12赫茲(Hz)的軟體可以使用Resting-State Data Analysis Toolkit (version 1.8)實現之,本發明並不加以限制。Finally, for the pre-processed whole brain MRI image processed by the image pre-processing means, this embodiment will further filter the pre-processed image with a frequency between 0.01-0.12 Hz through a band pass filter. Magnetic resonance imaging of the whole brain. Accordingly, the mean fractional amplitude of low-frequency fluctuations (mfALFF) information of the whole brain that can be used for training is extracted. In this embodiment, the software whose filtering frequency is between 0.01-0.12 hertz (Hz) can be realized by using the Resting-State Data Analysis Toolkit (version 1.8), which is not limited by the present invention.
而由於本實施例用於訓練的樣本數量總共為120名,因此一共會產出120筆的全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊用以訓練本實施例之體積卷積神經網路模型。在本實施例的訓練過程中,體積卷積神經網路模型的成長率透過Tensoflow及Keras higher API架構其成長率(growth rate)為16。接著,來自5名乳癌化療後倖存者的全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊以及5名的健康對照組的全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊將被作為測試集(test set);相對地,其餘110名之全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊將用以訓練,並且透過10摺交叉驗證(10-fold cross validation)驗證其訓練結果。Since the total number of samples used for training in this embodiment is 120, a total of 120 whole brain average low-frequency fluctuations (Mean fractional amplitude of low-frequency fluctuations, mfALFF) information will be generated for training The volumetric convolutional neural network model of the embodiment. In the training process of this embodiment, the growth rate of the volumetric convolutional neural network model is 16 through the framework of Tensoflow and Keras higher API. Next, the whole brain mean fractional amplitude of low-frequency fluctuations (mfALFF) information from 5 breast cancer survivors after chemotherapy and the whole brain mean fractional amplitude of low-frequency fluctuations (mfALFF) from 5 healthy controls (Mean fractional amplitude of low-frequency fluctuations, mfALFF) information will be used as the test set (test set); ) information will be used for training, and its training results will be verified through 10-fold cross validation.
在本實施例中,所有被輸入體積卷積神經網路模型的影像樣本(即全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊)之輸入尺寸(input size)均為64 × 64 × 64 × 1。而所有超過體積卷積神經網路模型輸入尺寸的影像樣本均透過網格搜索法(grid-search method)進行預定義(predefined)。In this embodiment, the input size (input size) of all image samples input into the volumetric convolutional neural network model (that is, the mean fraction amplitude of low-frequency fluctuations (mfALFF) information of the whole brain) ) are 64 × 64 × 64 × 1. All image samples exceeding the input size of the volumetric convolutional neural network model are predefined by a grid-search method.
進一步地,本實施例之體積卷積神經網路模型使用SGD學習優化器(SGD optimizer)進行訓練,並且學習率(Learning Rate)設定為1e-2。而批次尺寸(batch size)則設定至5。L2回歸因子(regularization factor)則被預定義為1e-4。除此之外,本實施例更使用隨機旋轉資料法(random rotation data method)將資料進行擴增,以避免影像樣本的擬合過度(overfitting)。最後,本實施例將體積卷積神經網路模型的訓練期程(training epoch)設定為200個期程(epoch)。Further, the volumetric convolutional neural network model of this embodiment is trained using an SGD optimizer (SGD optimizer), and the learning rate (Learning Rate) is set to 1e-2. And the batch size (batch size) is set to 5. The L2 regression factor (regularization factor) is predefined as 1e-4. In addition, in this embodiment, a random rotation data method is used to amplify the data to avoid overfitting of image samples. Finally, in this embodiment, the training epoch of the volumetric convolutional neural network model is set to 200 epochs.
最後,本實施例體積卷積神經網路模型中,3D-ResNet-50深度學習模型及3D-DenseNet-121深度學習模型的表現(performance)如下表1所示:
據此,訓練出可用於本實施例化療腦影像可視化分類系統的運作方法之體積卷積神經網路模型。Accordingly, a volumetric convolutional neural network model that can be used in the operating method of the chemotherapy brain image visualization classification system of this embodiment is trained.
因此如圖2所示,首先,本實施例步驟(A)中,當化療腦影像可視化分類系統10中的處理模組100收受到新的至少一原始全腦磁振造影影像後,會進一步執行步驟(B),該處理模組100會以前述說明過的影像前處理手段(即統計參數圖譜(Statistical Parametric Mapping, SPM))來處理作為靜息態功能性磁振造影(resting-state fMRI)的至少一原始全腦磁振造影影像。最後獲得至少一前處理後全腦磁振造影影像。Therefore, as shown in FIG. 2, first, in step (A) of this embodiment, after the
接著,步驟(C)係同樣由處理模組100對該至少一前處理後全腦磁振造影影像擷取出至少一全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊。據此,便完成輸入前述已經訓練好的體積卷積神經網路模型之前置作業。Next, in step (C), the
進一步地,本實施例之體積卷積神經網路模型會透過該處裡模組100運行。因此,步驟(D)係由處理模組100將該至少一全腦平均低頻波動振幅度分率資訊輸入前述已經訓練好的體積卷積神經網路(Volumetric Convolutional Neural Network)模型進行預測,並得到至少一全腦預測結果。Further, the volumetric convolutional neural network model of this embodiment will run through the
最後,步驟(E)係由處理模組100透過一積分梯度(integrated gradients)演算法將該至少一全腦預測結果轉換為至少一全腦腦區影像。而該至少一全腦腦區影像即可直接輸出至顯示器上,以視覺化的方式直接呈現不同腦區(至少包含額葉、顳葉、頂葉與枕葉)預測之全腦內基於體素的基礎代謝活性。Finally, in step (E), the
在本實施例中,所述積分梯度(integrated gradients)演算法的函式如下: 其中, i代表積分梯度的維度(dimension),x和x’依序代表原始輸入影像(Original input image)以及基線影像(Baseline image),F為該體積卷積神經網路模型;並且,該原始輸入影像為前述的至少一全腦平均低頻波動振幅度分率(Mean fractional amplitude of low-frequency fluctuations, mfALFF)資訊。 In this embodiment, the function of the integrated gradients algorithm is as follows: Among them, i represents the dimension of the integral gradient, x and x' represent the original input image (Original input image) and the baseline image (Baseline image) in sequence, F is the volume convolutional neural network model; and, the original The input image is the aforementioned at least one whole brain mean low-frequency fluctuations (Mean fractional amplitude of low-frequency fluctuations, mfALFF) information.
在本實施例中,所述基線影像(Baseline image)係以64 × 64 × 64 × 1解析度的全零三維影像(all-zero 3D images)實施之。同樣地,處理模組100係可以透過TensorFlow此一軟體來運行所述積分梯度(integrated gradients)演算法。因此,就可視化的影像呈現上,本實施例可視化的影像解析度同樣以64 × 64 × 64 × 1進行呈現。並且,梯度影像(gradient images)的繪製閾值設定為0.45。In this embodiment, the baseline image (Baseline image) is implemented with all-zero 3D images (all-zero 3D images) with a resolution of 64×64×64×1. Likewise, the
據此,請參照圖3,圖3係本發明化療腦影像可視化分類系統的運作方法所預測出的全腦腦區影像。如圖3所示,圖3右側不同的色階即可對應經過本實施例中體積卷積神經網路(Volumetric Convolutional Neural Network)模型以及積分梯度(integrated gradients)演算法依序進行預測及可視化後的全腦內各個腦區基於體素的基礎代謝活性圖(即全腦腦區影像),提供給醫護進行輔助判斷。Accordingly, please refer to FIG. 3 . FIG. 3 is an image of the whole brain region predicted by the operating method of the chemotherapy brain image visualization classification system of the present invention. As shown in Figure 3, the different color scales on the right side of Figure 3 can correspond to the volumetric convolutional neural network (Volumetric Convolutional Neural Network) model and integrated gradients (integrated gradients) algorithm in this embodiment for sequential prediction and visualization The voxel-based basic metabolic activity map of each brain region in the whole brain (that is, the image of the whole brain brain region) is provided to doctors and nurses for auxiliary judgment.
惟以上所述者,僅為本發明之較佳實施例而已,當不能以此限定本發明實施之範圍,即依本發明申請專利範圍及說明內容所作之簡單變化與修飾,皆仍屬本發明涵蓋之範圍內。But what is described above is only a preferred embodiment of the present invention, and should not limit the scope of implementation of the present invention, that is, the simple changes and modifications made according to the patent scope and description of the present invention still belong to the present invention within the scope covered.
10:化療腦影像可視化分類系統
100:處理模組
200a:儲存模組
200b:儲存模組
(A)~(E):步驟
10: Chemotherapy Brain Imaging Visual Classification System
100:
圖1係本發明化療腦影像可視化分類系統實施例之系統架構圖。 圖2係本發明化療腦影像可視化分類系統的運作方法實施例之流程圖。 圖3係本發明化療腦影像可視化分類系統的運作方法所預測出的全腦腦區影像。 FIG. 1 is a system architecture diagram of an embodiment of the visualized classification system for chemotherapy brain images of the present invention. Fig. 2 is a flow chart of an embodiment of the operation method of the chemotherapy brain image visualization classification system of the present invention. FIG. 3 is the image of the whole brain region predicted by the operation method of the chemotherapy brain image visualization classification system of the present invention.
(A)~(E):步驟 (A)~(E): Steps
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111138792A TWI796278B (en) | 2022-10-13 | 2022-10-13 | Chemo-brain image visualization classifying system and operating method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111138792A TWI796278B (en) | 2022-10-13 | 2022-10-13 | Chemo-brain image visualization classifying system and operating method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI796278B true TWI796278B (en) | 2023-03-11 |
TW202416285A TW202416285A (en) | 2024-04-16 |
Family
ID=86692429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111138792A TWI796278B (en) | 2022-10-13 | 2022-10-13 | Chemo-brain image visualization classifying system and operating method thereof |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI796278B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200237284A1 (en) * | 2019-01-24 | 2020-07-30 | Neeyanth KOPPARAPU | System and method for mri image synthesis for the diagnosis of parkinson's disease using deep learning |
CN112041026A (en) * | 2018-04-30 | 2020-12-04 | 医科达有限公司 | Radiation therapy treatment plan modeling using generative countermeasure networks |
CN113920243A (en) * | 2021-09-22 | 2022-01-11 | 深圳先进技术研究院 | Three-dimensional reconstruction method and device of brain structure in extreme environment and readable storage medium |
CN114419309A (en) * | 2022-01-07 | 2022-04-29 | 福州大学 | High-dimensional feature automatic extraction method based on brain T1-w magnetic resonance image |
-
2022
- 2022-10-13 TW TW111138792A patent/TWI796278B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112041026A (en) * | 2018-04-30 | 2020-12-04 | 医科达有限公司 | Radiation therapy treatment plan modeling using generative countermeasure networks |
US20200237284A1 (en) * | 2019-01-24 | 2020-07-30 | Neeyanth KOPPARAPU | System and method for mri image synthesis for the diagnosis of parkinson's disease using deep learning |
CN113920243A (en) * | 2021-09-22 | 2022-01-11 | 深圳先进技术研究院 | Three-dimensional reconstruction method and device of brain structure in extreme environment and readable storage medium |
CN114419309A (en) * | 2022-01-07 | 2022-04-29 | 福州大学 | High-dimensional feature automatic extraction method based on brain T1-w magnetic resonance image |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10733788B2 (en) | Deep reinforcement learning for recursive segmentation | |
US9888876B2 (en) | Method of analyzing multi-sequence MRI data for analysing brain abnormalities in a subject | |
EP3884862A1 (en) | Method and system for individualized prediction of mental illness on basis of brain function map monkey-human cross-species migration | |
CN108122221B (en) | Segmentation method and device for cerebral ischemia area in diffusion weighted imaging image | |
US20170236283A1 (en) | Image analysis method supporting illness development prediction for a neoplasm in a human or animal body | |
EP2987114B1 (en) | Method and system for determining a phenotype of a neoplasm in a human or animal body | |
KR102131687B1 (en) | Parkinson's disease diagnosis apparatus and method | |
JP2016508769A (en) | Medical image processing | |
US9155506B2 (en) | Method and system for processing MRT data of the human brain | |
CN109949288A (en) | Tumor type determines system, method and storage medium | |
Li et al. | Interpreting age effects of human fetal brain from spontaneous fMRI using deep 3D convolutional neural networks | |
CN114450716A (en) | Image processing for stroke characterization | |
Yo et al. | Quantifying brain connectivity: a comparative tractography study | |
TWI796278B (en) | Chemo-brain image visualization classifying system and operating method thereof | |
Çelebi et al. | Leveraging Deep Learning for Enhanced Detection of Alzheimer's Disease Through Morphometric Analysis of Brain Images. | |
Schilling et al. | Patch2self denoising of diffusion mri in the cervical spinal cord improves repeatability and feature conspicuity | |
Mahanand et al. | An enhanced effect-size thresholding method for the diagnosis of Autism spectrum disorder using resting state functional MRI | |
TW202416285A (en) | Chemo-brain image visualization classifying system and operating method thereof | |
KR102363221B1 (en) | Diagnosis Method and System of Idiopathic Normal Pressure Hydrocephalus Using Brain Image | |
Wang et al. | Semi-automatic segmentation of the fetal brain from magnetic resonance imaging | |
KR102319326B1 (en) | Method for generating predictive model based on intra-subject and inter-subject variability using structural mri | |
Amini et al. | Application of machine learning methods in diagnosis of alzheimer disease based on fractal feature extraction and convolutional neural network | |
Lu et al. | An Alzheimer's disease classification method based on ConvNeXt | |
Manochandar et al. | Classification of Alzheimer’s Disease using Neuroimaging Techniques | |
Tabassum et al. | A Deep Learning Framework for Skull Stripping in Brain MRI |